№ files_lp_4_process_1_40689
File format: docx
Character count: 161524
File size: 559 KB
The document presents detailed study characteristics and results from multiple research studies on plasma and urine biomarkers used in kidney disease, with specific data on TNFR1, FGF23, KIM-1, and other biomarkers across different cohorts and treatment conditions.
Year:
2013-2018
Region / City:
Global
Subject Area:
Renal disease biomarkers
Document Type:
Research supplement
Author:
Multiple authors (Lee, Nowak, Nadkarni, etc.)
Target Audience:
Researchers, healthcare professionals in nephrology and diabetes
Period of Action:
2013-2018
Approval Date:
N/A
Date of Changes:
N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2025
Region / City:
N/A
Subject:
Molecular MRI Biomarkers, Research Funding
Document Type:
Application Instructions and Checklist
Institution:
N/A
Author:
N/A
Target Audience:
Principal Investigators, Researchers in the field of Molecular MRI
Effective Period:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
2026
Region / city:
Not specified
Theme:
Pediatrics, Biomarkers
Document type:
Research Table
Institution:
Not specified
Author:
Not specified
Target audience:
Medical professionals, researchers
Period of validity:
Not specified
Approval date:
Not specified
Date of amendments:
Not specified
Version:
GastricHER2Biomarkers 1.0.0.1
Protocol Posting Date:
June 2017
Year:
2017
Region / city:
United States
Topic:
HER2 biomarker testing, gastric cancer, gastroesophageal junction
Document type:
Guideline
Organization / institution:
College of American Pathologists, American Society for Clinical Pathology, American Society of Clinical Oncology
Author:
Angela N. Bartley, MD; Jessi Christ, CTR; Patrick Fitzgibbons, MD; Stanley R. Hamilton, MD; Sanjay Kakar, MD; Manish A. Shah, MD; Laura H. Tang, MD, PhD; Megan L. Troxell MD, PhD
Target audience:
Pathologists, oncologists, clinical laboratories
Period of validity:
Indefinite
Date of approval:
June 2017
Date of changes:
N/A
Year:
2020
Region / Institution:
University College London
Programme:
DPUK Work Package 5
Related Work Packages:
WP3 (UK Biobank), WP4 (1946 birth cohort), WP6
Thematic Area:
Neurodegenerative diseases and biomarkers
Diseases Covered:
Familial Alzheimer’s disease, Familial frontotemporal dementia, Huntington’s disease, Familial Parkinson’s disease (LRRK2)
Cohorts:
UCL FAD, DIAN, GENFI, Track HD, LRRK2 cohort
Type of Document:
Research programme summary and output report
Organ / Institution:
University College London
Collaborating Initiatives:
DIAN, GENFI, Track HD, UK Biobank
Main Biomarkers Studied:
Serum neurofilament light (NfL), plasma phospho-tau181, cortical mean diffusivity, PET imaging markers
Study Population:
Individuals with autosomal dominant inherited neurodegenerative diseases and non-mutation carrier siblings
Research Focus:
Presymptomatic to symptomatic disease progression and biomarker validation
Outputs:
Peer-reviewed publications and longitudinal cohort analyses
Year:
2023
Region / city:
Global
Subject:
Postoperative biomarkers, colorectal cancer
Document Type:
Research data
Institution:
Various research institutions
Author:
Multiple authors
Target Audience:
Researchers, medical professionals
Effective Period:
N/A
Approval Date:
24.02.2023
Revision Date:
N/A
Note:
Contextual description
Version:
1.1.0.0
Protocol Posting Date:
March 2023
Year:
2023
Region / City:
Not specified
Topic:
Gynecologic cancer biomarker testing
Document Type:
Protocol
Organization / Institution:
Not specified
Author:
Barbara A. Crothers, DO; Lara R. Harik, MD, FCAP; Angela N. Bartley, MD, PhD, FCAP; Russell R. Broaddus, MD, PhD, FCAP; Linus T. Chuang, MD; Michael B. Cohen, MD; Patricia Salter Jamieson, CTR; Elke A. Jarboe, MD; Teri A. Longacre, MD; George L. Mutter, MD; Christopher N. Otis, MD; Patrick L. Fitzgibbons, MD, FCAP; Richard Zaino, MD; Gulisa Turashvili, MD, PhD; Krisztina Hanley, MD.
Target Audience:
Laboratories performing biomarker testing
Effective Period:
Not specified
Approval Date:
March 2023
Date of Changes:
Version 1.1.0.0
Version History:
Updated to include "COMMENT" section and revised notes
Year:
2026
Region / City:
Global
Topic:
Biomarkers, Diagnostics, Statistical Methods
Document Type:
Workshop Program
Organization:
PharmaLex, Biogen, Eli Lilly, Takeda, AstraZeneca
Authors:
Erin Wagner, Jake Gagnon, Hui-Rong Qian, Shuguang Huang, Brad Carlin, Helen You, Larry Gould, Zhe Sun, Bruno Boulanger, Ixavier Alonzo Higgins, Hoang Tran, Adarsh Joshi, Steven Novick
Target Audience:
Researchers, Biopharma Professionals, Data Scientists
Period of Action:
2026
Approval Date:
2026
Date of Changes:
N/A
Year:
2020
Region / city:
Worldwide
Topic:
Colorectal cancer, ctDNA
Document type:
Review article
Organization / institution:
Not specified
Author:
Not specified
Target audience:
Researchers, oncologists, medical professionals
Effective date:
Not specified
Date of changes:
Not specified
Year:
2022
Region / city:
New South Wales, Australia
Topic:
Sudden Infant Death Syndrome (SIDS)
Document type:
Commentary
Author:
Emma Matthews
Target audience:
Healthcare professionals, researchers in pediatric neurology, and SIDS
Period of validity:
N/A
Approval date:
N/A
Date of changes:
N/A
Keywords:
Sudden Unexpected Death in Infancy, Butyrylcholinesterase, Biomarkers, Sudden Infant Death Syndrome, Research
Contextual description:
Commentary on a study linking butyrylcholinesterase activity levels with Sudden Infant Death Syndrome, suggesting a potential predictive biomarker for SIDS.
Document type:
Supplementary scientific material
Section:
Supplement 9
Scientific field:
Microbiome research
Research area:
Gynecologic pathology
Methodology:
Random forest classifier models
Analytical approach:
Microbiome signature identification
Validation method:
Receiver operating characteristic curves
Cohorts analyzed:
Cohort A; Cohort C
Histological comparisons:
Serous histology vs benign; Endometrioid histology vs benign
Subject:
Biomarker discovery based on histological classification
Journal:
Journal of Applied Life Sciences International
Manuscript Number:
Ms_JALSI_151529
Article Title:
Dietary Bioactives as Genomic Regulators: A Critical Review of Gene Control, Biomarker Validation, and Translational Barriers in Nutrigenomics
Article Type:
Review Article
Document Type:
Peer Review Report
Reviewer:
Sumon Rahman Chowdhury
Reviewer Affiliation:
Chittagong Diabetic General Hospital
Country:
Bangladesh
Subject Area:
Nutrigenomics; Nutrigenetics; Epigenetics; Precision Nutrition
Key Scientific Topics:
Gene regulation by dietary bioactives, biomarkers, molecular mechanisms, obesity-related genes, translational barriers
Genes and Pathways Mentioned:
NRF2, NF-κB, FFAR1, FTO, GLUT4, PPARγ, leptin
Methodological Note:
Recommendation to describe methodology as “a narrative critical review using structured literature search”
Ethical Issues Statement:
No ethical issues reported
Purpose of Document:
Evaluation and revision recommendations for a submitted scientific manuscript
Year:
2018–2020
Document type:
Laboratory manual
Subject:
Urine specimen collection procedures
Prepared by:
Amal Hussain Atef, Senior Lab Technologist
Reviewed by:
Mona Faraj, Lab Supervisor
Approved by:
Dr. Abul Jalaluddin Bhuiyan, Head of Section
Intended users:
Laboratory staff, healthcare personnel, patients
Scope:
Patient preparation, specimen collection, transport, and documentation
Specimen types:
Random urine, first morning urine, timed urine, 24-hour urine, midstream clean catch, catheter specimen, suprapubic aspiration
Associated documents:
Urine Collection Instruction to Male Patients (Appendix A); Urine Collection Instruction to Female Patients (Appendix B)
Note:
Year
Organization / Institution:
Canberra Health Services
Target Audience:
Healthcare workers, medical staff, nurses, midwives
Year:
2026
Region:
Not specified
Document type:
Supplementary material / Research data
Methods:
LC-MS/MS, IP–HILIC–MS/MS
Analytes:
Tenofovir (TFV), Tenofovir-diphosphate (TFV-DP)
Sample types:
Urine, Dried Blood Spots (DBS)
Target population:
Participants on antiretroviral therapy (ART)
Measured variables:
Urine TFV concentration, DBS TFV-DP concentration, POC TFV results, self-reported adherence, viral load, drug resistance
Instrument:
Agilent HPLC coupled to AB Sciex 5500 triple quadrupole mass spectrometer
Software:
Analyst v1.6.2
Detection method:
Negative-ion multiple reaction monitoring (MRM)
Tables included:
S1, S2, S3, S4
Year:
2026
Region / City:
Not specified
Topic:
Urinary dipstick tests, Sediment analysis
Document Type:
Research data
Institution:
Not specified
Author:
Not specified
Target audience:
Researchers, medical professionals
Period of validity:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Contextual description:
A research document detailing the processing pipeline and results of urinary dipstick tests for different sample groups, as well as sediment analysis for urine samples.
Year:
2023
Region / City:
United Kingdom
Subject:
Fetal renal function, pregnancy
Document type:
Research article
Author:
Udoamaka Ezuruike, Alexander Blenkinsop, Amita Pansari, Khaled Abduljalil
Target audience:
Researchers, healthcare professionals, obstetricians, nephrologists
Period of action:
Pregnancy period
Date of approval:
Not provided
Date of amendments:
Not provided
Keywords:
Fetus, Pregnancy, Urine Production, Renal function, Creatinine, PBPK
Note:
Context
Year:
N/A
Region / City:
N/A
Topic:
Protein estimation in urine
Document Type:
Lab procedure
Institution:
N/A
Author:
N/A
Target audience:
Laboratory personnel, researchers
Period of validity:
N/A
Approval date:
N/A
Date of modifications:
N/A
Context description:
A laboratory procedure for quantitatively estimating protein concentration in urine using turbidimetric methods with sulfosalicylic acid.
Year:
2023
Region / city:
West Hills, CA, United States
Topic:
Kidney allograft rejection monitoring
Document type:
Research article
Organization / institution:
Thermo Fisher Scientific
Authors:
McFaul M, Ventura C, Evans S, Dundar H, Rumpler MJ, McCloskey C, Lowe D, Vlassov AV
Target audience:
Researchers, clinicians in organ transplant and diagnostics
Period of validity:
2023
Date of approval:
October 23, 2023
Date of changes:
None
Keywords:
Kidney allograft, Post-transplant monitoring, Liquid biopsy, Exosome, mRNA, Quantitative polymerase chain reaction
Corresponding author:
Alexandre V Vlassov, PhD
Summary:
Research on the stability of mRNA from urine-derived exosomes for kidney allograft rejection detection, including effects of sample transportation, storage, and interference substances.
Year:
2026
Region / City:
Belfast, Northern Ireland, UK
Topic:
Pediatric urine sampling, clinical research
Document Type:
Information sheet for research participants
Organization / Institution:
Queen’s University Belfast
Authors:
Dr Tom Waterfield, Professor Kerry Woolfall
Target Audience:
Children aged 12+ and their parents/guardians
Study Period:
2026–2027
Approval Date:
2026
Funding:
National Institute for Health and Care Research, Health Technology Assessment Programme
Sponsor:
Queen’s University Belfast
Data Protection:
GDPR compliance
Methods Covered:
Clean catch, catheterisation, suprapubic aspiration
Participation:
Voluntary, with option to withdraw at any time
Follow-up:
Questionnaire and optional interview for participants and parents